|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/18 | |
| A61K 31/195 | |||
| A61K 31/635 | |||
| A61P 29/00 |
| (11) | Patento numeris | 2207541 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08836080.5 |
| Europos patento paraiškos padavimo data | 2008-09-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-07-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/007953 |
| Data | 2008-09-20 |
| (87) | Numeris | WO 2009/043495 |
| Data | 2009-04-09 |
| (30) | Numeris | Data | Šalis |
| 07019521 | 2007-10-05 | EP | |
| 15256 | 2007-12-20 | US | |
| 08013725 | 2008-07-31 | EP |
| (72) |
RUDOLPHI, Karl, DE
MICHAELIS, Martin, DE
GUEHRING, Hans, DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (54) | USE OF SULFONYL-SUBSTITUTED 2-SULFONYLAMINOBENZOIC ACID N-PHENYLAMIDES IN THE TREATMENT OF PAIN |
| USE OF SULFONYL-SUBSTITUTED 2-SULFONYLAMINOBENZOIC ACID N-PHENYLAMIDES IN THE TREATMENT OF PAIN |